Buy PASSAGE BIO Stock | PASG Stock Price & Latest News | Public.com

PASSAGE BIO

$0.00 (0.00%)Today

    About PASG

    Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options. The company assembles a portfolio of genetic medicine product...Read more

    Community

    People who own or watch this stock

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Rating

    What Wall St. analysts suggest for this stock

    1.5

    Price Targets

    What analysts think this stock will be worth

    $25.31
    current
    $28.50
    average

    Events

    List of events that could affect this stock.

    11May

    Earnings data Q1 2020

    11Aug

    Earnings data Q2 2020

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.33
    -0.67
    -1
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.79

    Actual EPS
    Q3 2020

    Stats

    Market Cap$1,18B
    Volume6,53k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$38.23
    1 Year Low$8.09
    Open$26.58
    High$26.59
    Low$25.13

    Buy any stock with any amount of money.

    Download the App
    Download the app